Research output: Contribution to journal › Article › peer-review
Selection of Diagnostically Significant Regions of the SLC26A4 Gene Involved in Hearing Loss. / Danilchenko, Valeriia Yu; Zytsar, Marina V.; Maslova, Ekaterina A. et al.
In: International Journal of Molecular Sciences, Vol. 23, No. 21, 13453, 11.2022.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Selection of Diagnostically Significant Regions of the SLC26A4 Gene Involved in Hearing Loss
AU - Danilchenko, Valeriia Yu
AU - Zytsar, Marina V.
AU - Maslova, Ekaterina A.
AU - Posukh, Olga L.
N1 - Funding Information: This work was supported by the Russian Science Foundation grant No 21-75-00030, https://rscf.ru/en/project/21-75-00030/ (to M.V.Z., E.A.M. and V.Y.D.) and by the Ministry of Education and Science of Russian Federation (grant No FSUS-2020-0040) (to O.L.P.). Publisher Copyright: © 2022 by the authors.
PY - 2022/11
Y1 - 2022/11
N2 - Screening pathogenic variants in the SLC26A4 gene is an important part of molecular genetic testing for hearing loss (HL) since they are one of the common causes of hereditary HL in many populations. However, a large size of the SLC26A4 gene (20 coding exons) predetermines the difficulties of its complete mutational analysis, especially in large samples of patients. In addition, the regional or ethno-specific prevalence of SLC26A4 pathogenic variants has not yet been fully elucidated, except variants c.919-2A>G and c.2168A>G (p.His723Arg), which have been proven to be most common in Asian populations. We explored the distribution of currently known pathogenic and likely pathogenic (PLP) variants across the SLC26A4 gene sequence presented in the Deafness Variation Database for the selection of potential diagnostically important parts of this gene. As a result of this bioinformatic analysis, we found that molecular testing ten SLC26A4 exons (4, 6, 10, 11, 13–17 and 19) with flanking intronic regions can provide a diagnostic rate of 61.9% for all PLP variants in the SLC26A4 gene. The primary sequencing of these SLC26A4 regions may be applied as an initial effective diagnostic testing in samples of patients of unknown ethnicity or as a subsequent step after the targeted testing of already-known ethno- or region-specific pathogenic SLC26A4 variants.
AB - Screening pathogenic variants in the SLC26A4 gene is an important part of molecular genetic testing for hearing loss (HL) since they are one of the common causes of hereditary HL in many populations. However, a large size of the SLC26A4 gene (20 coding exons) predetermines the difficulties of its complete mutational analysis, especially in large samples of patients. In addition, the regional or ethno-specific prevalence of SLC26A4 pathogenic variants has not yet been fully elucidated, except variants c.919-2A>G and c.2168A>G (p.His723Arg), which have been proven to be most common in Asian populations. We explored the distribution of currently known pathogenic and likely pathogenic (PLP) variants across the SLC26A4 gene sequence presented in the Deafness Variation Database for the selection of potential diagnostically important parts of this gene. As a result of this bioinformatic analysis, we found that molecular testing ten SLC26A4 exons (4, 6, 10, 11, 13–17 and 19) with flanking intronic regions can provide a diagnostic rate of 61.9% for all PLP variants in the SLC26A4 gene. The primary sequencing of these SLC26A4 regions may be applied as an initial effective diagnostic testing in samples of patients of unknown ethnicity or as a subsequent step after the targeted testing of already-known ethno- or region-specific pathogenic SLC26A4 variants.
KW - bioinformatic analysis
KW - hearing loss
KW - molecular testing
KW - pathogenic variants
KW - pendrin
KW - SLC26A4
KW - Humans
KW - Mutation
KW - Hearing Loss/diagnosis
KW - Sulfate Transporters/genetics
KW - Hearing Loss, Sensorineural/genetics
KW - Deafness/genetics
UR - http://www.scopus.com/inward/record.url?scp=85141619084&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/7ddf0aae-fcb1-3350-9eb3-fc8eb065f77a/
U2 - 10.3390/ijms232113453
DO - 10.3390/ijms232113453
M3 - Article
C2 - 36362242
AN - SCOPUS:85141619084
VL - 23
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1661-6596
IS - 21
M1 - 13453
ER -
ID: 39331363